Study of dissolution behavior of matrices tablets based on alginate - Gelatin mixtures as prolonged diltiazem hydrochloride release systems

Drug Development and Industrial Pharmacy

Volumn 33, Issue 6, 2007, Pages 585-593

  Tapia, Cristián ^a   Ormazabal, Víctor ^a   Costa, Edda ^a   Yazdani Pedram, Mehrdad ^a  

^a UNIVERSITY OF CHILE   (Chile)

Author keywords

Alginate; Gelatin; Matrices; Prolonged drug release

Indexed keywords

ALGINIC ACID; DILTIAZEM; G 2500; G 9382; GELATIN; GELATIN TYPE A; GELATIN TYPE B; POLYELECTROLYTE; UNCLASSIFIED DRUG;

ARTICLE; DRUG SOLUBILITY; GASTROINTESTINAL TRACT; GEL; MATRIX TABLET; PH; SIMULATION; SUSTAINED DRUG RELEASE;

ALGINATES; CHEMISTRY, PHARMACEUTICAL; DELAYED-ACTION PREPARATIONS; DILTIAZEM; ELECTROLYTES; GELATIN; HYDROGELS; HYDROGEN-ION CONCENTRATION; KINETICS; SOLUBILITY; SOLVENTS; TABLETS; TIME FACTORS;

EID: 34447118859     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.1080/03639040601085359     Document Type: Article

References (21)

1. Brondsted, H., & Kopecek, J. (1992). pH-sensitive hydrogels. In Polyelectrolyte Gels; Harland, R. S., Prud'homme, R. K., Eds.; ACS Symposium Series.: Washington, pp. 285-304.
2. Caramella, C., Ferrari, F., Bonferoni, M., Sangalli, M., Bernardi, M., Feletti, F., & Galmozzi, M. (1993). In vitro/ in vivo correlation of prolonged release dosage form containing diltiazem HCl. Biopharm. Drugs Dispos., 14, 143-160.
3. Das, S., & Gupta, B. (1998). Simulation of physiological ph-time profile in vitro dissolution study : relationship between dissolution rate and bioavailability of controlled release dosage form. Drug Dev. Ind. Pharm., 14, 537-544.
4. Dornish, M., Kaplan, D., & Skaugrud, O. (2001). Standards and guidelines for biopolymers in tissue-engineered medical products. Ann. N.Y. Acad. Sci., 944, 388-397.
5. Giunchedi, P., Gavini, E., Moretti, M. D., & Pirisino, G. (2000). Evaluation of alginate compressed matrices as prolonged drug delivery systems. AAPS PharmSciTech., 1, E19.
6. Kalyanasundaram, S., Feinstein, S., Nicholson, J. P., Leong, K. W., & Garver, R. I. (1999). Coacervate microspheres as carriers of recombinant adenoviruses. Cancer Gene Ther., 6, 107-112.
7. Kim, H., & Fassihi, R. (1997). Application of a binary polymer system in drug release rate modulation.1. Characterization of release mechanism, J. Pharm. Sci., 86, 316-322.
8. Kulkarni, A. R., Soppimath, K. S., Aminabhavi, T. M., Rudzinski, W. E. (2001). In-vitro release kinetics of cefadroxil-loaded sodium alginate interpenetrating network beads. Eur J Pharm Biopharm., 51, 127-133.
9. Liew, C., Chan, L. W., Ching, A. L., & Heng, P. W. S. (2006). Evaluation of sodium alginate as drug release modifier in matrix tablets. Int. J. Pharm., 309, 25-37.
10. Lin, S. Y., & Ayres, J. W. (1992). Calcium alginate beads as core carriers of 5-aminosalcylic acid. Pharm. Res., 9, 1128-1131.
11. Liu, P., & Krishnan, T. R. (1999). Alginate-pectin-poly-L- lysine particulate as a potential controlled release formulation. J. Pharm. Pharmacol., 511, 41-149.
12. Martinsen, A., Storro, I., & Skjak-Break, G. (1992). Alginate as immobilization Material: III. Difussional properties. Biotechnol. Bioeng., 39, 186-194.
13. Moe, S., Draget, K., Skjak-Braek, G., & Smidsrod, O. (1995). Alginates. In Food Polysaccharides and their applications, Stephen, A., Ed., Marcel Dekker, Inc.: New York, pp. 245-286.
14. Michailova, V., Titeva, St., Kotsilkova, R., Krusteva, E., & Minkov, E. (2000). Water uptake and relaxation processes in mixed unlimited swelling hydrogels. Int. J. Pharm., 209, 45-56.
15. Narayani, R., & Rao, K. P. (1995). Polymer-coated gelatin capsules as oral delivery devices and their gastrointestinal tract behaviour in humans. J. Biomater. Sci. Polym. Ed., 7, 39-48.
16. Østberg, T., Lund, E. M., & Graffner, C. (1994). Calcium alginate matrices for oral multiple unit administration: IV. Release characteristics formulation in different media. Int. J. Pharm., 112, 241-248.
17. Rose, I. P. (1990). In Kroschwitz, J. I. (Ed.) Concise Encyclopedia of Polymer Science and Engineering (pp. 428-430). New York: John Wiley & Sons.
18. Tapia, C., Corbalán, V., Costa, E., Gai, M. N., & Yazdani-Pedram, M. (2005). Study of the release mechanism of diltiazem hydrochloride from matrices based on chitosan-alginate and chitosancarrageenan mixtures. Biomacromolecules, 6, 2389-2395.
19. Tapia, C., Costa, E., Moris, M., Sapag-Hagar, J., Valenzuela, F., & Basualto, C. (2002). Study of the influence of the pH media dissolution, degree of polymerization, and degree of swelling of the polymers on the mechanism of release of Diltiazem from matrices based on mixtures chitosan-alginate. Drug Dev. Ind. Pharm., 28, 217-224.
20. The United States Pharmacopeia XXIV, 24th Rev., United States Pharmacopeial Convention, Rockville, 2000.
21. Tonnesen, H. H., & Karlsen, J. (2002). Alginate in drug delivery systems. Drug Dev. Ind. Pharm., 28, 621-630.